Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talineuren in Parkinson Disease
NCT06431971Phase 2Not yet recruiting
- Sponsor
- InnoMedica
- Start
- Jan 2027
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of talineuren in Parkinson's disease (PD), sponsored by InnoMedica. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
talineuren
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06431971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431971.